According to BioNexus Gene Lab's latest financial reports the company has a price-to-book ratio of 1.08.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.9696 | -96.08% |
2022-12-31 | 24.8 | -51.25% |
2021-12-31 | 50.8 | 43.22% |
2020-12-31 | 35.5 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.89 | 167.61% | ๐บ๐ธ USA |